HEALTH UNION is proud to announce the launch of its first project Migraine.com, the largest, most engaging online destination dedicated solely to Migraine disease and headache. Read the press release.

Migraine disease can have an enormous impact on the lives of patients and their loved ones. Whether a visitor has just started experiencing the symptoms of Migraine disease or has been a Migraine sufferer for years, Migraine.com strives to provide visitors with tools and resources to help manage the disease. Although there is no cure for Migraine disease, we hope the information provided by patients, caregivers, and healthcare professionals at Migraine.com will help improve our visitors quality of life.

Migraine.com features more than 1500 articles and stories of original content on Migraine disease and headache, written in plain english by an experienced team of advocates, physicians, and healthcare professionals - in addition to features such as Ask The Experts, the Migraine Meter (our migraine journal), Migraine Report (our migraine journal), and Migraine Stories.

The Migraine.com Weekly, our e-mail newsletter, features the latest migraine news, featured migraine stories and more.

The Migraine Meter allows users to track, store and share information about their attacks such as pain level, symptoms, potential triggers, environmental factors and treatment effectiveness - either online, or via free iOS and Android applications.

The Migraine Report collects user information from the journal and other online activities into a document suitable for sharing with a doctor or caregiver.

Migraine impacts each individual in a unique way and there are a wide range of triggers, treatment strategies, and pain management approaches. And many Migraine sufferers feel alone and isolated. Migraine Stories on Migraine.com allows patients to share their stories and learn from one another.

We're social. In addition to all of the features on the Migraine.com website itself, Health Union has also established a robust presence on Facebook and Twitter.